Corvus Pharmaceuticals, Inc. (CRVS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$15.58
Day's range
$16.48

Corvus Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ORBIMED ADVISORS LLC 08/14/2026 7.17 M $107.05 M   0.00% 7.76%
BLACKROCK, INC. 08/07/2026 7.14 M $106.65 M   15.88% 7.73%
STATE STREET CORP 09/22/2026 4.47 M $66.84 M   25.47% 4.97%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 3.79 M $56.61 M   29.88% 4.10%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 3.29 M $49.19 M   1.80% 3.56%
ADAMS STREET PARTNERS LLC 08/14/2026 3.28 M $48.94 M   0.00% 3.55%
VIVO CAPITAL, LLC 08/14/2026 2.81 M $41.92 M   0.00% 3.04%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 2.73 M $40.81 M   17.82% 2.96%
PERCEPTIVE ADVISORS LLC 08/14/2026 2.67 M $39.85 M   16.36% 2.89%
DEEP TRACK CAPITAL, LP 08/14/2026 2.49 M $37.23 M   0.02% 2.70%
BRAIDWELL LP 08/14/2026 2.13 M $31.77 M   21.31% 2.30%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 1.85 M $27.70 M   8.23% 2.01%
FORESITE CAPITAL MANAGEMENT VI LLC 08/14/2026 1.83 M $27.36 M   0.00% 1.98%
GOLDMAN SACHS GROUP INC 08/14/2026 1.58 M $23.55 M   2.31% 1.71%
HOOD RIVER CAPITAL MANAGEMENT LLC 08/14/2026 1.57 M $23.48 M   17.73% 1.70%
MORGAN STANLEY 08/13/2026 1.34 M $20.09 M   -46.19% 1.46%
BOXER CAPITAL MANAGEMENT, LLC 08/14/2026 1.10 M $16.43 M   0.00% 1.19%
CATALIO CAPITAL MANAGEMENT, LP 08/14/2026 1.08 M $16.15 M   21.18% 1.17%
MILLENNIUM MANAGEMENT LLC 08/14/2026 1.05 M $15.66 M   20.96% 1.13%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 814.75 K $12.17 M   21.62% 0.88%
TWO SIGMA INVESTMENTS, LP 08/14/2026 785.21 K $11.73 M   45.44% 0.85%
BANK OF AMERICA CORP /DE/ 08/14/2026 757.80 K $11.32 M   219.74% 0.82%
ADAGE CAPITAL PARTNERS GP, L.L.C. 08/14/2026 750.00 K $11.21 M   0.00% 0.81%
EVERSEPT PARTNERS, LP 08/14/2026 747.99 K $11.18 M   100.00% 0.81%
EMERALD ADVISERS, LLC 08/05/2026 685.68 K $10.24 M   -0.08% 0.74%
DCF ADVISERS, LLC 08/10/2026 637.50 K $9.52 M   0.00% 0.69%
BLUE OWL CAPITAL HOLDINGS LP 08/11/2026 608.60 K $9.09 M   11.67% 0.66%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 585.00 K $8.74 M   7.66% 0.63%
NORTHERN TRUST CORP 08/13/2026 575.16 K $8.59 M   13.64% 0.62%
EMERALD MUTUAL FUND ADVISERS TRUST 08/05/2026 526.39 K $7.86 M   14.62% 0.57%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 520.53 K $7.78 M   3.15% 0.56%
RA CAPITAL MANAGEMENT, L.P. 08/14/2026 450.00 K $6.72 M   0.00% 0.49%
NEXTECH INVEST, LTD. 08/14/2026 450.00 K $6.72 M   0.00% 0.49%
CITADEL ADVISORS LLC 09/02/2026 446.80 K $6.68 M   66.84% 0.48%
CITADEL ADVISORS LLC 09/02/2026 397.95 K $5.95 M   -10.07% 0.43%
UBS GROUP AG 08/13/2026 396.12 K $5.92 M   37.01% 0.43%
BARCLAYS PLC 08/14/2026 315.75 K $4.72 M   29.52% 0.34%
JUMP FINANCIAL, LLC 08/13/2026 313.40 K $4.68 M   111.97% 0.34%
TREXQUANT INVESTMENT LP 08/14/2026 296.35 K $4.43 M   100.00% 0.32%
DIADEMA PARTNERS LP 08/14/2026 294.81 K $4.40 M   20.42% 0.32%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 274.50 K $4.10 M   47.26% 0.30%
POLYMER CAPITAL MANAGEMENT (HK) LTD 08/13/2026 263.66 K $3.94 M   43.93% 0.29%
BREVAN HOWARD CAPITAL MANAGEMENT LP 08/14/2026 250.29 K $3.74 M   49.01% 0.27%
SPHERA FUNDS MANAGEMENT LTD. 08/14/2026 244.96 K $3.66 M   -1.21% 0.27%
SPRUCE STREET CAPITAL LP 08/13/2026 231.59 K $3.46 M   0.00% 0.25%
SEB ASSET MANAGEMENT AB 08/04/2026 226.84 K $3.39 M   0.00% 0.25%
VICTORY CAPITAL MANAGEMENT INC 08/07/2026 220.76 K $3.30 M   72.00% 0.24%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 08/13/2026 217.75 K $3.25 M   159.51% 0.24%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 208.12 K $3.11 M   10.63% 0.23%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 208.12 K $3.11 M   100.00% 0.23%

Corvus Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 233 institutional investors and hedge funds held shares of Corvus Pharmaceuticals Inc. The most heavily invested institutionals were:

EASTERN BANK: 92

Versant Capital Management, Inc: 28

ORBIMED ADVISORS LLC: 7.17 M

BlackRock, Inc.: 7.14 M

STATE STREET CORP: 4.47 M

PRICE T ROWE ASSOCIATES INC /MD/: 3.79 M

76.79% of Corvus Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 77.66 M shares in the last 24 months. This purchase volume represents approximately $1.23 B in transactions.